Sanofi Adds Biologics to Its AI Ambitions, Striking Up R&D Alliance With BioMap

Formed by Baidu founder and CEO Robin Li, BioMap uses artificial intelligence technology to glean insight into proteins to guide biologic drug discovery. The startup is the latest company to join a growing list of Sanofi partners as the pharmaceutical giant continues investing in AI-enabled drug discovery.

The post Sanofi Adds Biologics to Its AI Ambitions, Striking Up R&D Alliance With BioMap appeared first on Above the Law.

Related Articles

Responses

Your email address will not be published. Required fields are marked *